Expiry of the Gatifloxacin Ophthalmic Solution Out-Licensing Agreement

An individual event involving the termination, upon expiration of the contract term, of the technology transfer agreement with Allergan for gatifloxacin ophthalmic solution. It concerns a theme tied to a specific product, counterparty, and termination of a technology transfer agreement.